tm logo

Monitor this mark

View On USPTO

ZELRAYMI
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 28 Oct 2024

Last Applicant/ Owned by

Genzyme Corporation

450 Water Street

Cambridge

MA

02142

Serial Number

90531821 filed on 17th Feb 2021

Registration Number

N/A

Correspondent Address

Karen Lim

Karen Lim FROSS ZELNICK LEHRMAN & ZISSU, P.C.

NEW YORK, NY 10036

UNITED STATES

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ZELRAYMI

Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases, namely, lysosomal storage disorders and autosomal dominant polycystic kidney disease; pharmaceutical preparat Read More

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases, namely, lysosomal storage disorders and autosomal dominant polycystic kidney disease; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 90531821

Mark Type

No Service/Collective Mark

Attorney Docket Number

No GENZ 2102761

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
28th Oct 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
28th Oct 2024ABANDONMENT - NO USE STATEMENT FILED
13th Feb 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12th Feb 2024SOU EXTENSION 5 GRANTED
12th Feb 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
30th Jan 2024SOU EXTENSION 5 FILED
30th Jan 2024SOU TEAS EXTENSION RECEIVED
09th Aug 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07th Aug 2023SOU EXTENSION 4 GRANTED
07th Aug 2023SOU EXTENSION 4 FILED